Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2005
10/13/2005US20050226907 Pharmanutrient composition(s) and system(s) for individualized, responsive dosing regimens
10/13/2005US20050226906 Nutrient system for individualized responsive dosing regimens
10/13/2005US20050226905 Biocompatible compositions as carriers or excipients for pharmaceutical and nutraceutical formulations and for food protection
10/13/2005US20050226904 Fibrous composite for tissue engineering
10/13/2005US20050226903 Water-dispersible or water-soluble poloxamers provides a drug forms with good fracture strength, flexibility, and dimensional stability; counteract triglycerides brittleness; use of a medical stick for medical administration in body cavities and/or wound cavities; veterinary medicine
10/13/2005US20050226898 Compositions and methods for transdermal oxybutynin therapy
10/13/2005US20050226897 Method of protecting against coccidiosis
10/13/2005US20050226893 Lyophilization method to improve excipient crystallization
10/13/2005US20050226875 Uses of anti-CTLA-4 antibodies
10/13/2005US20050226851 Lysin-deficient bacteriophages having reduced immunogenicity
10/13/2005US20050226842 Nanoemulsions comprising at least one amphiphilic lipid, at least one oil, and at least one nonionic polymer, and uses thereof
10/13/2005US20050226823 Film-shaped preparations with improved chemical stability containing active substances and method for the production thereof
10/13/2005US20050226818 Anticholinergic powder formulations for inhalation
10/13/2005US20050224372 Multiple compartment bag assembly for dialysis fluid
10/13/2005US20050224201 Treated crimped multi-ply product
10/13/2005DE102004014704A1 Partikelstabilisierte Emulsionen Particle-stabilized emulsions
10/13/2005DE102004014013A1 Ein Gemisch enthaltend Fettalkohole und APG-ethercarboxylat A mixture containing fatty alcohols and APG ethercarboxylate
10/13/2005DE102004013637A1 Verfahren zur Herstellung von CS-Partikeln und Mikrokapseln unter Verwendung poröser Template sowie CS-Partikel und Mikrokapseln A process for the production of CS-particles and microcapsules using porous templates as well as CS-particles and microcapsules
10/13/2005CA2794424A1 Multi-vitamin and mineral nutritional supplements
10/13/2005CA2564643A1 Pharmaceutical compositions based on anticholinergics and ccr2 receptor antagonists
10/13/2005CA2561728A1 Bifunctional bioadhesive compositions for oral implantology
10/13/2005CA2561380A1 A composition containing a complex comprising a metal ion and a carboxylate ligand having anti-inflammatory activity
10/13/2005CA2561247A1 Serum-stable amphoteric liposomes
10/13/2005CA2560812A1 Coated tablet formulation and method
10/13/2005CA2558903A1 Stable coating agent comprising sterol
10/13/2005CA2557999A1 Methods and compositions for treatment of ion imbalances
10/13/2005CA2552542A1 Controlled release pharmaceutical composition of tolperisone for oral administration
10/13/2005CA2551797A1 Anionic hydrogel matrices with ph dependent modified release as drug carriers
10/13/2005CA2539043A1 Compositions capable of facilitating penetration across a biological barrier
10/12/2005EP1584879A2 Device for pulverising desiccated bulk product in a freeze-drying apparatus for foodstuffs, medicaments, and so forth
10/12/2005EP1584318A2 A method and dosage form for dispensing a bioactive substance
10/12/2005EP1584236A2 Fibre substrate provided with an antibacterial finish containing a metal complexed with a polymer
10/12/2005EP1583986A2 Biomedical devices with antimicrobial coatings
10/12/2005EP1583747A2 Inhibitors of phosphatases
10/12/2005EP1583713A1 Peptide nanostructures encapsulating a foreign material and method of manufacturing same
10/12/2005EP1583566A1 Self-adhesive polymer matrix containing sea algae extract and glycerin
10/12/2005EP1583559A1 Compositions for prevention and treatment of cold and influenza-like symptoms comprising select mucoadhesive polymers
10/12/2005EP1583545A2 Pharmaceutical composition for improved administration of hiv gp41-derived peptides, and its use in therapy
10/12/2005EP1583543A2 Methods and therapeutic compositions in the treatment of advanced cancer
10/12/2005EP1583520A1 PARTIALLY BIODEGRADABLE TEMPERATURE AND pH SENSITIVE HYDROGEL
10/12/2005EP1583519A1 High pressure compaction for pharmaceutical formulations
10/12/2005EP1583518A1 Immobilisation of dna-labelled lipid vesicles on dna arrays
10/12/2005EP1583517A2 Methods and products for treating staphylococcal infections
10/12/2005EP1583509A1 Orally administrable composition for improving hair and coat quality
10/12/2005EP1583506A2 Eye-drop vaccine containing copolymer 1 for therapeutic immunization
10/12/2005EP1583502A2 Methods and reagents for the enhancement of virus transduction in the bladder epithelium
10/12/2005EP1583458A2 Lipophilic electrophoretic probes
10/12/2005EP1583432A1 Homogeneous solid granules containing carotenoids
10/12/2005EP1583431A1 Edible film containing food acid
10/12/2005EP1539319A4 Crystallization system utilizing atomization
10/12/2005EP1474092A4 Micromesh interproximal devices
10/12/2005EP1335747A4 A composition of sodium channel blocking compound
10/12/2005EP1313467B1 Novel pharmaceutical composition for administering n-0923
10/12/2005EP1304991A4 Method and kit for moisturizing the surface of the eye
10/12/2005EP1294360B1 Process for the preparation of crystalline particles for inhalation
10/12/2005EP1216047B1 Combination of loteprednol and beta2-adrenoceptor agonists and its use by inhalation for the treatment of bronchial asthma
10/12/2005EP1206466B1 Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
10/12/2005EP1189587B1 Cosmetic or dermatological product comprising a freeze-dried hydrocolloid composition
10/12/2005EP1185249B1 Use of a biodegradable polymer
10/12/2005EP1169117B1 Process for producing particles using a supercritical fluid
10/12/2005EP1140848B1 Phenethyl-5-bromopyridylthiourea (pbt) derivatives exhibiting spermicidal activity
10/12/2005EP1140033B1 Improved controlled release compositions
10/12/2005EP1140027B1 Dosage forms comprising porous particles
10/12/2005EP1105104B1 Extended release buccal bioadhesive tablet
10/12/2005EP1072269B1 Use of dextrin, starch or glycogen for the treatment of bacterial vaginosis
10/12/2005EP1001772B1 Improved delivery of multiple doses of medications
10/12/2005EP0760240B1 Composition for stimulating the cerebral activity comprising vinpocetine citrate and a plant extract comprising xanthines
10/12/2005EP0731727A4 Polyhydroxybutyrate and polyphosphate membranes with channels
10/12/2005CN2732244Y Live Bifidobacterium, Lactobacillus, Enterococcus and Bacillus ceresu composite dispersible agent
10/12/2005CN2732243Y Live Bifidobacterium, Lactobacillus, Enterococcus and Bacillus ceresu composite capsule
10/12/2005CN2732242Y Copper metal embolizing agent
10/12/2005CN1682390A Method for manufacture of films containing insoluble solids embedded in cellulose-based films
10/12/2005CN1681846A Process for producing hydroxyalkyl starch derivatives
10/12/2005CN1681844A Hasylated polypeptides, especially hasylated erythropoietin
10/12/2005CN1681839A Proline ester and preparation containing the same for percutaneous administration
10/12/2005CN1681544A Infusion pump system, an infusion pump unit and an infusion pump
10/12/2005CN1681542A Controlled release device and method using electrothermal ablation
10/12/2005CN1681536A Method of preparing dry powder inhalation compositions
10/12/2005CN1681534A Drug absorbability improving agents
10/12/2005CN1681520A Dihydrate dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compostions thereof
10/12/2005CN1681509A Slow release preparation containing larmotriazine
10/12/2005CN1681497A Dispersible tablets for oral administration
10/12/2005CN1681496A Novel pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
10/12/2005CN1681493A Taste masked sumatriptan tablets and processes for their preparation
10/12/2005CN1681486A Pharmaceutical formulations of modafinil
10/12/2005CN1681485A Novel pharmaceutical formulations of modafinil
10/12/2005CN1681483A Improved oral microcapsule with low-solubility active component
10/12/2005CN1681482A Animal remedy preparation without animal products
10/12/2005CN1681481A Legemiddel inneholdende vardenafilhydrokloridtrihydrat
10/12/2005CN1681480A Galenic formulation for colon targeted delivery of active principles
10/12/2005CN1681479A Pharmaceutical compositions of semi-ordered drugs and polymers
10/12/2005CN1681478A Platinum aggregates and process for producing the same
10/12/2005CN1681455A A delivery system and a manufacturing process of a delivery system
10/12/2005CN1680657A Antibacterial composition and methods of making and using the same
10/12/2005CN1680463A Complex emulsions of perfluoropolyethers
10/12/2005CN1680445A Antithemolytic streptococcus, staphylococcus and candida albicans lgG antibody and preparation thereof
10/12/2005CN1680425A 6.alpha., 9.alpha.-difluoro-17.alpha.-'(2-furanylcaboxyl)oxy!-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1, 4,-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflamatory agent
10/12/2005CN1680423A Compounds useful in the manufacture of an anti-inflammatory androstane derivative
10/12/2005CN1680414A Preparation of Chinese medicine clinopodium polycephalum saponin
10/12/2005CN1680376A Polymorphs of n-methyl-n-(3-{3-[2-thienylcarbonyl]-pyrazol-[1, 5- alpha ]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
1 ... 1738 1739 1740 1741 1742 1743 1744 1745 1746 1747 1748 1749 1750 1751 1752 1753 1754 1755 1756 1757 1758 ... 2991